Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BeiGene logo — BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology...

BeiGene

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

Founded 2010 United States Cambridge, United States 2164 employees IPO Total: $6.69B

General Information

Company Name BeiGene
Founded Year 2010
Location United States Cambridge, United States +22
Employees 2164
Funding Stage IPO
Social

Get notified when BeiGene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BeiGene

BeiGene, now rebranding as BeOne Medicines Ltd., is a notable player in the life sciences biotechnology sector. Founded in 2010, the company has been instrumental in developing innovative cancer therapies.

The company recently changed the name of its U.S. subsidiary to BeOne Medicines USA, Inc. as part of a strategic move to align with its anticipated global rebranding. The rebranding aims to reinforce its mission to advance medical innovations and collaborate with the global community, with plans to redomicile to Switzerland, contingent upon shareholder consent.

Financially, BeiGene maintains a robust position with a significant investment marked by a $1.00B Post IPO Debt funding received on November 1, 2025. This demonstrates investor confidence in the company's strategic directions and future prospects.

Taxonomy: life sciences, innovative medicines, cancer treatment, immuno-oncology, hematology, oncology, targeted therapy, global rebranding, patient partnerships, pharmaceutical development, therapeutic innovation, global healthcare, redomiciliation, shareholder engagement

Services & Products

Cancer Treatment Development
Clinical Research and Trials
Patient Assistance Programs
Biopharmaceutical Manufacturing

Target Customers

Cancer Patients Healthcare Providers Medical Researchers Investors

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Debt •••••• - 01 Nov 2025
Post Ipo Equity •••••• 1
Investor
01 Aug 2025
Post Ipo Equity •••••• 1 •••• •••• 01 Dec 2019
Secondary Market •••••• - 01 Aug 2018
Post Ipo Equity •••••• - 01 Jan 2018

View All 9 Funding Rounds

BeiGene Alternatives & Competitors

View All Alternatives
BeiGene vs
BeiGene
BeiGene United States

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicin...

1985 employees
BeiGene vs
BeOne Medicines
BeOne Medicines

Creating next-generation cancer treatments for all.

BeiGene vs
ALBINO LIFESCIENCES PRIVATE LIMITED
ALBINO LIFESCIENCES PRIVATE LIMITED India

We are the gem of excellence in care.....

56 employees
Manufacturing, Pharmaceutical
Compare BeiGene vs ALBINO LIFESCIENCES PRIVATE LIMITED
Also compare with: BeiGene vs pharma& pharma& BeiGene vs Takeda Oncology Takeda Oncology View all alternatives

FAQ About BeiGene

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company
BeiGene was founded in 2010.
BeiGene is headquartered in Cambridge, United States.
BeiGene has approximately 2164 employees.
BeiGene has completed 9 funding rounds, raising a total of $6.69B. The latest funding stage is IPO.
BeiGene offers: Cancer Treatment Development, Clinical Research and Trials, Patient Assistance Programs, Biopharmaceutical Manufacturing.
Top alternatives and competitors to BeiGene include BeiGene, BeOne Medicines, ALBINO LIFESCIENCES PRIVATE LIMITED, Axter Therapeutics, pharma&. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BeiGene and BeiGene are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BeiGene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy